Leavitt Chase C.'s Form 4 filing
Oncternal Therapeutics, Inc. (ONCT) · filed Apr 14, 2023
- Accession no.
- 0001209191-23-024264
- Filed
- Apr 14, 2023, 6:00 AM ET
- Trade date
- Apr 12-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $7.25K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leavitt Chase C.CIK 0001777467 | Officer (General Counsel/Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2023 | Common Stock | PPurchaseAcquired | +15,000 | $0.29 | +$4,350 | 96,901 | Direct | |
| Apr 13, 2023 | Common Stock | PPurchaseAcquired | +10,000 | $0.29 | +$2,900 | 106,901 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.